Management of patients with asymptomatic moderate aortic stenosis undergoing coronary artery bypass grafting

Gilles D Touati1, Doron Carmi, Faouzi Trojette

  • 1Department of Cardiovascular Surgery, Centre Hospitalier et Universitaire d'Amiens, Hĵpital Sud, France.

Insights

Manual decalcification of the aortic valve is a viable option for patients with moderate aortic stenosis undergoing coronary artery bypass grafting. This procedure can improve aortic valve area and potentially delay stenosis progression.

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Valvular Heart Disease

Background:

  • Moderate aortic stenosis (AS) often coexists with coronary artery disease.
  • Surgical intervention for coronary artery disease presents an opportunity to address concomitant AS.

Purpose of the Study:

  • To evaluate manual aortic valve decalcification as a treatment for moderate AS during coronary artery bypass grafting (CABG).
  • To assess if manual valve debridement can delay the natural progression of AS.

Main Methods:

  • Prospective study of 14 adult patients with moderate AS undergoing CABG.
  • Manual debridement of aortic valve calcifications and restoration of cusp mobility.
  • Concomitant myocardial revascularization with an average of 2.38 grafts per patient.

Main Results:

  • Significant improvement in mean aortic valve area index (AVAI) post-surgery (0.56 to 1.43 cm²/m²).
  • Slowest recalcification rates observed in patients with specific AVAI ratios, minimal change in aortic insufficiency, and higher preoperative AVAI (>0.55 cm²/m²).

Conclusions:

  • Manual aortic valve decalcification is a beneficial option for moderate AS in patients requiring CABG.
  • Optimal outcomes achieved in patients with senile tricuspid aortic valve stenosis and AVAI of 0.55-0.9 cm²/m².
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...